SCHEMBL9252896

SCHEMBL9252896

CN(CCC(=O)O)S(=O)(=O)c1ccc2c(c1)nc(-c1ccc(C(=N)N)cc1)n2C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
RECQL P46063 1/20 0.50
KMT2A Q03164 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.46
F2 P00734 13/20 0.46
HDAC1 Q13547 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
SLC22A2 O15244 1/20 0.43
F10 P00742 1/20 0.43
PLG P00747 1/20 0.43
PLAT P00750 1/20 0.43
PROC P04070 1/20 0.43
HPN P05981 1/20 0.43
PRSS1 P07477 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9253990 0.92 CA1 (0.47) MEN1RECQLKMT2ACA12CA1
SCHEMBL9251086 0.84 CA1 (0.50) MEN1RECQLKMT2ACA12CA1
SCHEMBL9252576 0.83 F2 (0.54) F2HDAC1HDAC8HDAC6SLC22A2
SCHEMBL9252892 0.83 CA12 (0.48) MEN1RECQLKMT2ACA12CA1
SCHEMBL9252002 0.82 CA1 (0.52) CA12CA1CA2CA9ALDH1A1
SCHEMBL9249490 0.78 HDAC1 (0.56) F2HDAC1HDAC8HDAC6SLC22A2
SCHEMBL9251773 0.77 HDAC1 (0.50) F2HDAC1HDAC8HDAC6SLC22A2
SCHEMBL9255124 0.77 HDAC1 (0.50) F2HDAC1HDAC8HDAC6SLC22A2
SCHEMBL9253361 0.77 CA1 (0.48) CA12CA1CA2CA9ALDH1A1
SCHEMBL9248732 0.77 CA1 (0.50) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5434150-A Anticoagulants, cardiovascular disorders DR. KARL THOMAE GMBH (DE) 1995-07-18 US disclosed
EP-0531883-A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-03-17 EP disclosed